Two Sigma Advisers’s Encompass Health EHC Stock Holding History

Two Sigma Advisers’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-359,100	Closed	-$38.1M	–	667
2025 Q4	$38.1M	Buy	359,100 +139,700	+64%	+$16.2M	0.07%	222
2025 Q3	$27.9M	Buy	219,400 +25,735	+13%	+$3.06M	0.06%	254
2025 Q2	$23.7M	Buy	193,665 +98,365	+103%	+$11.2M	0.05%	306
2025 Q1	$9.65M	Buy	95,300 +31,500	+49%	+$3.08M	0.02%	541
2024 Q4	$5.89M	Buy	63,800 +36,800	+136%	+$3.61M	0.01%	656
2024 Q3	$2.61M	Sell	27,000 -800	-3%	-$71.9K	0.01%	954
2024 Q2	$2.38M	Sell	27,800 -4,200	-13%	-$352K	0.01%	1099
2024 Q1	$2.64M	Sell	32,000 -1,000	-3%	-$73.2K	0.01%	1077
2023 Q4	$2.2M	Buy	33,000 +100	+0.3%	+$6.48K	0.01%	1234
2023 Q3	$2.21M	Sell	32,900 -10,600	-24%	-$729K	0.01%	1139
2023 Q2	$2.95M	Sell	43,500 -4,000	-8%	-$251K	0.01%	1002
2023 Q1	$2.57M	Buy	47,500 +10,200	+27%	+$594K	0.01%	1150
2022 Q4	$2.23M	Buy	37,300 +4,600	+14%	+$250K	0.01%	1182
2022 Q3	$1.48M	Sell	32,700 -7,398	-18%	-$370K	﹤0.01%	1332
2022 Q2	$1.79M	Buy	40,098 +9,679	+32%	+$497K	0.01%	1277
2022 Q1	$1.72M	Buy	30,419 +10,684	+54%	+$558K	﹤0.01%	1350
2021 Q4	$1.02M	Sell	19,735 -13,827	-41%	-$713K	﹤0.01%	1548
2021 Q3	$2M	Sell	33,562 -116,999	-78%	-$7.36M	0.01%	1255
2021 Q2	$9.35M	Sell	150,561 -35,322	-19%	-$2.35M	0.02%	595
2021 Q1	$12.1M	Sell	185,883 -174,366	-48%	-$11.4M	0.03%	506
2020 Q4	$23.7M	Sell	360,249 -262,210	-42%	-$15.4M	0.06%	306
2020 Q3	$32.2M	Sell	622,459 -214,604	-26%	-$11M	0.09%	217
2020 Q2	$41.2M	Sell	837,063 -117,781	-12%	-$6.36M	0.12%	182
2020 Q1	$48.6M	Buy	954,844 +233,928	+32%	+$13.5M	0.19%	123
2019 Q4	$39.7M	Sell	720,916 -124,191	-15%	-$6.74M	0.09%	245
2019 Q3	$42.5M	Sell	845,107 -142,921	-14%	-$7.18M	0.1%	227
2019 Q2	$49.8M	Buy	988,028 +130,853	+15%	+$6.35M	0.12%	205
2019 Q1	$39.8M	Buy	857,175 +138,647	+19%	+$7.02M	0.1%	252
2018 Q4	$35.3M	Buy	718,528 +380,746	+113%	+$21.7M	0.1%	256
2018 Q3	$20.9M	Buy	337,782 +302,281	+851%	+$18.4M	0.05%	383
2018 Q2	$1.91M	Sell	35,501 -19,484	-35%	-$974K	0.01%	1320
2018 Q1	$2.5M	Buy	54,985 +4,651	+9%	+$199K	0.01%	1146
2017 Q4	$1.98M	Sell	50,334 -13,324	-21%	-$507K	0.01%	1250
2017 Q3	$2.35M	Buy	63,658 +20,992	+49%	+$748K	0.01%	1120
2017 Q2	$1.64M	Sell	42,666 -158,599	-79%	-$5.81M	0.01%	1300
2017 Q1	$6.86M	Buy	201,265 +168,709	+518%	+$5.54M	0.02%	690
2016 Q4	$1.07M	Buy	+32,556	New	+$1.06M	﹤0.01%	1521
2016 Q3	–	Sell	-7,470	Closed	-$231K	–	2231
2016 Q2	$231K	Sell	7,470 -49,498	-87%	-$1.55M	﹤0.01%	1816
2016 Q1	$1.71M	Sell	56,968 -50,783	-47%	-$1.4M	0.01%	871
2015 Q4	$2.98M	Buy	+107,751	New	+$3.07M	0.02%	621
2015 Q1	–	Sell	-228,675	Closed	-$7M	–	2032
2014 Q4	$7M	Sell	228,675 -23,631	-9%	-$737K	0.05%	393
2014 Q3	$7.41M	Buy	252,306 +45,503	+22%	+$1.39M	0.06%	379
2014 Q2	$5.9M	Sell	206,803 -59,959	-22%	-$1.67M	0.05%	427
2014 Q1	$7.63M	Sell	266,762 -28,282	-10%	-$736K	0.07%	304
2013 Q4	$7.82M	Buy	295,044 +39,972	+16%	+$1.11M	0.08%	279
2013 Q3	$7M	Sell	255,072 -228,145	-47%	-$5.86M	0.08%	252
2013 Q2	$11.1M	Buy	+483,217	New	+$10.9M	0.16%	122

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Two Sigma Advisers's EHC Position: Q1 2026 in Review

Two Sigma Advisers sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 359,100 shares — an estimated $38.1M sold.

Two Sigma Advisers first reported a position in EHC in Q2 2013 and held it in 47 quarters. The position peaked at $49.8M in Q2 2019. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

Two Sigma Advisers reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 359,100 Encompass Health shares in Q1 2026, an estimated $38.1M.
Two Sigma Advisers first reported a position in Encompass Health in Q2 2013 and held it in 47 quarters.
Two Sigma Advisers's Encompass Health position peaked at $49.8M in Q2 2019.
577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.